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Deartmenth of
For these reasons we chose to investigate liquid chromatography. We believe thatthepresent procedure is suited for widespread use in the routine clinical laboratory.
Materials and Methods

Apparatus
We used a Model LC-150 "high-performance" liquid chromatograph equipped with an electrochemical detector con-aisting of a TL-5 cell (glassy carbon electrode) and an LC-4B 
Reagents and Standards
Chemicals. Adjust to pH 6.5 with 1 mol/L HC1, saturatethe mixture with sodium chloride, and extract it with two 20-mL aliquota ofethylacetatefora total of 45 mm. Evaporate the combined ethyl acetateextracts under reduced pressure, at room temperature. Redissolve the residue in 1 mL of distilled water and inject 500-L aliquots onto the preparative column. Using a flow rate of 2 mL/min, collect the fractions corresponding to the largest peak in the chromatogram and store them at -10 #{176}C without any further purification.
The concentration of iso-MHPG in the pooled fractions was calculated to be 60 mgfL (on the assumption that equimolar amounts ofMHPG and iso-MHPG give the same response in the refractive index detector).
The stock 1 g/L standard solution ofMHPG was prepared by dissolving 123.4mg ofthe piperazine salt in 100 mL of 0.01 molJL HC1. Stored at 4#{176}C, this standard is stable for at least three months. The 0.1 gfL working standard, prepared on the day of analysis by diluting the stock 10-fold with distilled water, was used toprepare aqueous calibrators of 1, 2, and 3 mgfL. Controls. A lyophilized pooled specimen of urine from healthy persons was used for quality control and studies on day-to-day precision.
Reagents.
Buffer solutions: 1 molJL sodium acetate (anhydrous), adjusted to pH 6.0 with glacial aceticacid;50 g/L Na2EDTA; 0.1 mol/L H3BO3; 0.5 mol/L Na2B4O7 10 H20 adjusted to pH 10.5with 1 molfL NaOH; 0.1 molfL acetic acid containing 0.5 g each of Na2EDTA and Na2S2O5 per liter.
The mobile phase consisted of 50 mmoIIL KH2PO4 (adjusted to pH 2.5 with 85% phosphoric acid) and acetonitrile (88/12, by vol). Before use, the mobile phase was filtered through a membrane ifiter having a nominal pore size of 0.2 m (Raimn Instrument Co.,Woburn, MA 01801) and degassed by purging with helium for 15 mm.
Samples.
Twenty-four-hour urine specimens were collected over 0.5 g of Na2S2O5. During collection, the urine was maintained at 4 #{176}C. The volume of the specimen was recorded, and a 50-mL aliquot was stored at 4 #{176}C until analysis.
Procedure
In 16 x 150 mm glass culturetubes,mix 3-mL aliquots of urine, standard, or control with 
Results and Discussion
Chromatography. Figure 1 illustrates representative chromatograms from a saline blank, an aqueous standard, and a urine sample, each of which was hydrolyzed with glusulase and taken through the entire extraction procedure. The reagent blank shows no extraneous peaks. Different urine samples vary in the complexity of their chromatograms, so high-resolution columns must be used. Some urine specimens show an unidentified peak elutinglatein the chromatogram. To circumvent this potential problem, we routinely set the autoinjector for an injection every 20 mm.
Precision. We evaluated within-run precision by analyz- All patients' urine specimens have been analyzed withoutadding the internal standard and none have contained peaks with a retention time the same as that for iso-MHPG.
Extraction.
The extractionprocedure described here is essentially the same as thatof Santagostino et al.(12). In the original procedure, multiple extractions for unspecified periods oftime were performed at each step and the details of how the various pH adjustments were made were not included. In our hands, their final step, evaporation of the ethyl acetate before chromatography, caused erratic recovery of MHPG and introduced extraneous peaks. Our experience with an earlier procedure for sample clean-up (11) led us to substitute the final back-extraction into acetic acid. This single modification decreased the within-run CV from 7.4% to 1.8%.
Quantification. One of the most important improvements in existing liquid-chromatographic procedures for urinary MHPG was the inclusion of a suitable internal standard (11). Contrary to this earlier report (11), iso-MHPG is not commercially available. Attempts to substitute 3-methoxy-4-hydroxyphenylethyl alcohol, which had been used in gaschromatographic assays (7), not onlydecreased the precision of the assay but also required quantification by the method of standard additions because urine contains small but variable amounts of this compound.
For these reasons we prepared iso-MHPG, using essentially the same reaction previously used to synthesize deuterated homovanillyl alcohol (13). The identity of the product was confirmed by gas chromatography/massspectrometry. The electron impact spectra of thepentafluoropropionyl derivatives of MHPG and iso-MHPG, formed according to Correlation studies. During our initial investigation, aliquota of 20 patients' specimens were analyzed independently by an established reference laboratory that uses a gaschromatographic method (7) and in our laboratory by the present procedure. The linear regression of the liquidchromatographic (x) vs the gas-chromatographic (y) results was y = 1.44x + 0.16 (r = 0.78). Although the gaschromatographic assay is widely used, prediction of values from one assay to the other is apparently not reliable. A recent report (6) that compared MIIPG values by gas chromatography with those obtained by a reference procedure involving gas chromatography/mass spectrometry (correlation coefficient 0.61) raises concern regarding the validity of the gas-chromatographic procedure, as does an earlier observation that the gas-chromatographic Chim Acta 103, 109-1 16 (1980) . 14. Karoum F, Ruthven CRJ, Sandler M. Gas chromatographic assay of phenolic alcohols in biological material using electron capture detection. Biochem Med 5, 505-514 (1971) 
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